Ropinirole Other names: Ropinotergotirole

Chemical formula: C₁₆H₂₄N₂O  Molecular mass: 260.375 g/mol  PubChem compound: 5095

Active ingredient description

Ropinirole is a non-ergoline D2/D3 dopamine agonist which stimulates striatal dopamine receptors. Ropinirole alleviates the dopamine deficiency which characterises Parkinson’s disease by stimulating striatal dopamine receptors.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N04BC04 Ropinirole N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ROPIQUAL XL Prolonged-release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 91374-20-8
CAS Substance: 91374-21-9
DrugBank Drug: DB00268
KEGG Drug: D08489
PubChem Compound: 5095
RxNorm Ingredient: 72302
SNOMED-CT Concept: 372499000
Ropinirole (substance)
UNII Identifier: 030PYR8953
ROPINIROLE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.